Data coverage, completeness and provenance for NEUROTECH INTERNATIONAL LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T05:10:11. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0170 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0170 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0180 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0190 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0180 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/NTI/prices · Price parameters and adjustment semantics
Neurotech International Limited, a clinical-stage biopharmaceutical development company, focuses on development of solutions for paediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy in Australia. The company develops NTI164 to treat autism spectrum disorder, paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, paediatric acute-onset neuropsychiatric syndrome, and Rett syndrome. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary cannabis strains. The company has a collaboration with The University of Sydney. Neurotech International Limited was incorporated in 2016 and is based in Melbourne, Australia.
Website: https://neurotechinternational.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/NTI/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 20 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 24 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 24 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 25 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 28 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/NTI
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/NTI/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/NTI/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/NTI/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/NTI/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/NTI
Free tier — instant API key. Built for AI agents.